We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+15.67%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$207M
AUM Growth
+$32.9M
Cap. Flow
+$15.8M
Cap. Flow %
7.64%
Top 10 Hldgs %
19.08%
Holding
152
New
40
Increased
47
Reduced
19
Closed
43

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$3.26M
2
CHGG icon
Chegg
CHGG
+$3.09M
3
NOVT icon
Novanta
NOVT
+$2.99M
4
NVRO
NEVRO CORP.
NVRO
+$2.45M
5
TDOC icon
Teladoc Health
TDOC
+$2.22M

Sector Composition

Rank Sector Weight
1 Technology 25%
2 Healthcare 22.72%
3 Consumer Discretionary 15.17%
4 Industrials 15.07%
5 Financials 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRO
26
DELISTED
NEVRO CORP.
NVRO
$2.63M 1.27%
+30,370
New +$2.45M
GTT
27
DELISTED
GTT Communications, Inc.
GTT
$2.62M 1.26%
46,130
+16,150
+54% +$797K
PRAH
28
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.53M 1.22%
30,524
-3,320
-10% -$295K
RP
29
DELISTED
RealPage, Inc.
RP
$2.46M 1.19%
47,870
+17,380
+57% +$868K
IRTC icon
30
iRhythm Holdings
IRTC
$3.85B
$2.46M 1.19%
39,120
+16,950
+76% +$1.05M
MKSI icon
31
MKS Inc
MKSI
$20.1B
$2.44M 1.18%
21,107
+8,015
+61% +$880K
SKX
32
DELISTED
Skechers
SKX
$2.38M 1.15%
61,075
+21,175
+53% +$843K
TDOC icon
33
Teladoc Health
TDOC
$1.22B
$2.37M 1.15%
+58,893
New +$2.22M
BJRI icon
34
BJ's Restaurants
BJRI
$1.42B
$2.36M 1.14%
+52,515
New +$2.11M
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.57B
$2.33M 1.13%
31,520
+11,215
+55% +$748K
TITN icon
36
Titan Machinery
TITN
$396M
$2.33M 1.13%
99,100
+62,455
+170% +$1.31M
BPMC
37
DELISTED
Blueprint Medicines
BPMC
$2.28M 1.1%
24,860
+5,650
+29% +$487K
XENT
38
DELISTED
Intersect ENT, Inc
XENT
$2.25M 1.09%
57,380
+12,170
+27% +$445K
CONN
39
DELISTED
Conn's Inc.
CONN
$2.25M 1.09%
66,150
+13,780
+26% +$459K
LGND icon
40
Ligand Pharmaceuticals
LGND
$5.76B
$2.2M 1.06%
+21,376
New +$2.11M
KNX icon
41
Knight Transportation
KNX
$11.3B
$2.18M 1.05%
47,340
+31,985
+208% +$1.52M
FRPT icon
42
Freshpet
FRPT
$2.93B
$2.04M 0.99%
124,100
-51,440
-29% -$951K
GMED icon
43
Globus Medical
GMED
$10.7B
$2.01M 0.97%
+40,365
New +$1.9M
MBUU icon
44
Malibu Boats
MBUU
$541M
$1.96M 0.94%
58,880
+31,575
+116% +$1.03M
FIVN icon
45
FIVE9
FIVN
$2.11B
$1.92M 0.93%
+64,595
New +$1.77M
AMN icon
46
AMN Healthcare
AMN
$1.3B
$1.91M 0.92%
33,665
+17,635
+110% +$959K
SUPN icon
47
Supernus Pharmaceuticals
SUPN
$2.59B
$1.9M 0.92%
+41,445
New +$1.73M
LOPE icon
48
Grand Canyon Education
LOPE
$3.79B
$1.85M 0.89%
17,650
-10,000
-36% -$966K
XPO icon
49
XPO
XPO
$23.5B
$1.84M 0.89%
52,320
-144
-0.3% -$4.8K
TRHC
50
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1.84M 0.89%
47,405
+22,760
+92% +$798K

Similar funds

Lisanti Capital Growth's Q1 2018 Portfolio in Review

As of Q1 2018, Lisanti Capital Growth held 152 positions worth $207M, up 19% from $174M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth deployed $15.8M of net new capital in Q1 2018, opening 40 new positions and adding to 47 existing holdings. Its largest new stake was QuidelOrtho: 70,140 shares worth $3.63M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was RBC Bearings, an estimated $2.46M trimmed.

  • Lisanti Capital Growth's largest Q1 2018 buy was QuidelOrtho: 70,140 shares worth $3.63M.
  • Lisanti Capital Growth added most to Ameris Bancorp in Q1 2018, an estimated $1.75M increase.
  • Lisanti Capital Growth's biggest Q1 2018 reduction was RBC Bearings, cutting an estimated $2.46M.
  • Lisanti Capital Growth fully exited Terex in Q1 2018, selling an estimated $4.09M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $207M portfolio in Q1 2018.
  • Lisanti Capital Growth opened 40 new positions and closed 43 in Q1 2018.
  • Lisanti Capital Growth's portfolio value rose 19% quarter-over-quarter to $207M.

Based on Lisanti Capital Growth's 13F filing for Q1 2018, filed 15 May 2018.